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[~  Acute respiratory infections in young CF children 
B. van Ewijk, T.F.W Wolfs, A. Fleer, C.K. van der Ent. CF Centre Wilhelmina 
Children ~' Hospital, Utrecht, The Netherlands' 
Aims: Local defense is impaired in CF lung disease, which might imply a higher 
impact of acute respiratory infections (ARI). Acquisition of P aeruginosa (PA) 
has been associated with a preceding viral respiratory infection in CF patients.We 
hypothesised that ARI causes more symptoms in CF children compared to healthy 
controls (HC) and is associated with an increased rate of PA acquisition. 
Methods: In a 6 months period 20 PA free CF children aged 0 to 7 years and 
19 unrelated age-matched HC were contacted 2×/week with a standard survey 
regarding symptoms of ARI. If any symptom was present physical examination, 
naso- and oropharyngeal swabs for viral PCR analysis and bacterial culture were 
performed. 
Results: In CF we found 4.4 periods of ARI/child compared to 4.2 in HC, with 
no significant differences in upper espiratory tract symptoms. CF children showed 
significantly more cough with sputum (54 vs. 27×, p < 0.01), more dyspnea (18 vs. 
6×, p 0.04), higher respiratory rate (32.2 vs. 25.9/min, p < 0.01), lower oxygen 
saturation (96.2 vs 97.4%, p 0.02) and more abnormal auscultation compared to 
HC (21 vs. 7×, p 0.02). In a sample of 99 nasopharyngeal swabs we found a viral 
pathogen i  64% (36/56) in CF children, compared to 53% (23/43, p 0.42) in HC. 
Higher than expected numbers of children had at least one PA positive culture, 6 
of 20 CF patients (30%) compared to 7 of 19 HC (37%). Follow-up cultures were 
always negative for PA in HC, while in 4 of 6 (67%) CF children they remained 
positive for PA. 
Conclusions: Young CF children have as many ARI as healthy children, but more 
lower respiratory tract symptoms.Viral ssociated ARI are frequently linked with 
PA acquisition in both CF and healthy children.While healthy children easily clear 
PA, this often results in a persistent infection in CF children. 
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Use of anaerobic bacteriological culture for the detection of 
anaerobic bacteria in sputum from Cystic Fibrosis patients 
T.R. Field 1 , A. McDowell 2, S. Patrick 2, J.S. Elborn 3, M.M. Tunney 1. 1Clinical 
and Practice Research Group, School of Pharmacy, 2Department of Microbiology 
and Immunobiology, School of Medicine, 3Respiratory Medicine Research Group, 
Queen ~' University Belftst, Belfast BT9 7BL, UK 
Pulmonary infection by Pseudomonas aeruginosa is the leading cause of morbidity 
and mortality in Cystic Fibrosis (CF) patients. The reduced oxygen concentration 
observed in the sputa of CF patients coupled with respiration of P aeruginosa is 
believed to create anoxic zones within the CF lung. If the airway mucus of CF 
patients is anaerobic, there is the potential that these anoxic zones contain obligate 
anaerobes which may also contribute to the infection. 
In this study, we used strict anaerobic bacteriological culture techniques to detect 
anaerobic bacteria in sputa samples from CF patients colonized with P aeruginosa. 
Potential anaerobes were checked for oxygen sensitivity and identified by 16S rDNA 
PCR. 
Anaerobes were detected in 80% of the 60 samples examined to date and the total 
viable count of the majority of anaerobes i olated from each individual patient 
was equal to or exceeded the total viable count of E aeruginosa isolated from that 
same patient. Anaerobes isolated have belonged to the genus's Bifidobacterium, 
Prevotella, Veillonella, and Propionibacterium. 
These results indicate that anaerobes are present in the lungs of CF patients in 
significant numbers and may, therefore, contribute to a polymicrobial infection in 
the lungs of CF patients. 
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Respiratory failure, driven by bacterial infection, leads to mortality in the majority 
of CF patients. Our understanding of these bacteria has been deepened by applying 
molecular profiling techniques uch as T-RFLP to sputum samples. T-RFLR 
which characterises the total bacterial community without prior growth, avoids 
biases associated with culture-based techniques. These studies have reported a 
significantly higher level of bacterial diversity than observed previously by using 
diagnostic ulture-based analyses. The vast majority of species detected were not 
those regarded as traditional CF pathogens e.g. Pseudomonas aeruginosa. Here, we 
compare sputum sampled from CF patients attending either an American or a British 
CF clinic. This allowed the extent of similarity of lung bacterial communities from 
both patient sets to be determined. These data were used to test hypotheses relating 
to the impact of geographical separation on the bacterial communities present in the 
lungs of CF patients. In order to do so, sputa from patients at Southampton a d UNC 
were subjected to T-RFLP profiling of the 16S rRNA gene. Initial findings uggest 
species diversity was slightly lower in US than UK samples (9.5±1.5 and 13.3±7.9 
respectively). For both sample sets, P aeruginosa was the dominant species (c.60% 
of cases), with non-"key CF pathogens" dominant in remaining samples. However, 
further investigation is vital to determine the generic significance of these findings. 
Studies uch as these will deepen our understanding of the geographical component 
to CF lung infection and may provide new strategies that will improve the treatment 
of lung disease. 
The physiological state of Pseudomonas aeruginosa populations 
in lungs of Cystic Fibrosis (CF) patients 
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In the research of chronic infections in CF patients, we focused on the growth 
characteristics o fP  aeruginosa to understand better the persistence of the infection. 
P aeruginosa isolates from 6 chronically infected CF patients grow 2 3 fold slower 
than environmental isolates in laboratory media. We indirectly measured growth 
rates of the bacteria in sputum samples (reflecting the in vivo conditions in the 
lung) using quantitative fluorescent in situ hybridization (FISH). Different clinical 
isolates were cultivated in various media resulting in a range of growth rates, 
and 16S rRNA targeted quantitative FISH was applied to measure the amount 
of ribosomal RNA per cell volume at each growth rate. Based upon these standard 
curves, estimates of the in situ growth rates of P aeruginosa in CF sputum were 
derived from determinations of the rRNA content in a large number of single cells in 
individual sputum samples. The result showed that most of the cells were growing 
with rates of 0.2 0.5/h, some even faster. Only small stationary sub-populations 
seemed to be present in the sputum samples. This suggests a high turnover ate 
of bacterial biomass in the CF lung, most likely caused by antibiotic treatment, 
immune system attacks and/or emoval of biomass by coughing. Consequently the 
bacterial population may be confronted with two opposing selection forces: One in 
favour of reduced growth rates, perhaps coupled to a high stress level in the CF 
lung, and another in favour of fast growth coupled to competition for nutrients. 
This scenario constitutes a new perspective on the adaptation of P aeruginosa in 
chronically infected CF patients, which must be taken into consideration i  relation 
to the design of antibiotic therapies. 
